| cranial nerve disease | ||||
| Disease ID | 1920 |
|---|---|
| Disease | cranial nerve disease |
| Integrated Phenotype | (Waiting for update.) |
| Text Mined Phenotype | (Waiting for update.) |
| Disease ID | 1920 |
|---|---|
| Disease | cranial nerve disease |
| Manually Symptom | (Waiting for update.) |
| Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
|---|
| (Waiting for update.) |
All Snps(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Annotation(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Snp Trait(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
Mapped by lexical matching(Total Items:0) |
|---|
| (Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
|---|
| (Waiting for update.) |
Chemical(Total Drugs:5) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
| C0010266 | cisplatin | D002945 | 15663-27-1 | cranial nerve diseases | MESH:D003389 | marker/mechanism | 3509048 | ||
| C0010266 | methotrexate | D008727 | 1959/5/2 | cranial nerve diseases | MESH:D003389 | marker/mechanism | 2297635 | ||
| C0010266 | pyridoxine | D011736 | - | cranial nerve diseases | MESH:D003389 | therapeutic | 15838404 | ||
| C0010266 | thalidomide | D013792 | 50-35-1 | cranial nerve diseases | MESH:D003389 | marker/mechanism | 9200351 | ||
| C0010266 | vincristine | D014750 | - | cranial nerve diseases | MESH:D003389 | marker/mechanism | 10390891 | ||
FDA approved drug and dosage information(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |
FDA labeling changes(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |